← Back to all trials
Suspended
NCT03623464
RCT of Mobile Apps & FitBit v. Usual Care
Conditions: Pancreatic Cancer, Gastric Cancer, Hepatic Cancer, Colon Cancer, Rectal Cancer, Small Bowel Cancer
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Phase: NA
Enrollment: 107
Sponsor: Weill Medical College of Cornell University
Location: Weill Cornell Medicine- New York Presbyterian New York New York
Summary
This is a randomized clinical trial to evaluate the use of mobile devices in preventing readmission in patients undergoing major GI cancer operations.
Eligibility Criteria
Inclusion Criteria:
1. Subject is 18 years or older
2. Subject speaks English
3. Subject owns a smart phone
4. Subject is scheduled to undergo surgery for a GI cancer (pancreatic, hepatic, gastric, small bowel, colon, or rectal cancers)
Exclusion Criteria:
1. Physician deems the subject is unable to complete the study due to documented dementia
2. Subject is undergoing emergent surgery
3. Subject has sepsis from another source
4. Physician deems the subject is unable to complete the study due to documented alcohol and/or drug abuse
Source: ClinicalTrials.gov (NCT03623464). StuddyBuddy aggregates publicly available trial information.
